Out of the 41 analysts that have coverage on Sun Pharma, 30 of them have a 'Buy' rating on the stock. Seven of them have a 'Hold' rating, while only four of them have a 'Sell' recommendation.
Shares of Suzlon Energy Ltd have gained 21% in the last four sessions ahead of Union Budget 2025. The multibagger stock, which closed at Rs 50.25 on January 28 hit a high of Rs 61.05 on BSE in early ...
As questions continue about air traffic control staffing in D. C. after the tragic jet collision earlier this week, we wanted to find out what the staffing situation is in San Diego.
Citi said that deleveraging at the holding company, resilience in commodity prices, potential medium-term aluminium upside and likely completion of the demerger process keeps them bullish on Vedanta ...